A beneficial levels of 25-hydroxyvitamin D for a decrease in thyrotropin receptor antibody (TRAB) in patients with Graves’ disease: a real-world study

A beneficial levels of 25-hydroxyvitamin D for a decrease in thyrotropin receptor antibody (TRAB) in patients with Graves’ disease: a real-world study

Abstract Objective This study aimed to determine whether a relationship exist between pre-therapy 25-hydroxyvitamin D levels and the remission/negative conversion rates of thyrotropin receptor antibody (TRAB) during treatment in patients with newly diagnosed Graves’ disease (GD). Methods 171 patient...

Full description

Saved in:
Bibliographic Details
Main Authors: Xide Chen, Yongze Zhang, Luxi Lin, Yuxia Chen, Ximei Shen, Lingning Huang, Fengying Zhao, Sunjie Yan
Format: Article
Language:English
Published: BMC 2025-01-01
Series:BMC Endocrine Disorders
Subjects:
Graves’disease, 25-hydroxyvitamin D
TRAB remission rate
Negative conversion rate
Thyroid function
Online Access:https://doi.org/10.1186/s12902-024-01823-x
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s12902-024-01823-x

Similar Items